Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies... Research Beam Model: Research Beam Product ID: 116740 125 USD New
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
 
 

Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review

  • Category : Pharmaceuticals
  • Published On : April   2014
  • Pages : 42
  • Publisher : GlobalData
 
 
 
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Adherex Technologies Inc. (Adherex) is a US-based biopharmaceutical company that focuses on novel cancer treatments. It undertakes the discovery and development of new treatments for cancer focusing on tumor cells and tumor blood vessels. The company has two late stage clinical products: Sodium Thiosulfate (STS) and Eniluracil (EU). STS is a chemical reducing agent undergoing two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children. Eniluracil is an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which is being developed to improve the tolerability and effectiveness of 5-fluorouracil (5-FU).

Adherex Technologies Inc. Key Recent Developments

Mar 31, 2014: Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2013 Financial Results
Nov 22, 2013: Adherex announces closing of private placement
Nov 15, 2013: Adherex reports recent developments and third quarter September 30, 2013 financial results
Nov 15, 2013: Adherex announces private placement of units
Aug 15, 2013: Adherex Announces Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Adherex Technologies Inc. - Key Facts 5
Adherex Technologies Inc. - Key Employees 6
Adherex Technologies Inc. - Key Employee Biographies 7
Adherex Technologies Inc. - Major Products and Services 8
Adherex Technologies Inc. - Pharmaceutical Pipeline Products Data 9
Adherex Technologies Inc., Pipeline Products by Therapy Area 9
Adherex Technologies Inc., Pipeline Products by Development Phase 10
Adherex Technologies Inc. - History 12
Adherex Technologies Inc. - Company Statement 14
Adherex Technologies Inc. - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Adherex Technologies Inc. - Business Description 17
Adherex Technologies Inc. - Corporate Strategy 18
Adherex Technologies Inc. - SWOT Analysis 19
SWOT Analysis - Overview 19
Adherex Technologies Inc. - Strengths 19
Strength - Broad Patent Portfolio 19
Strength - Restructuring Initiatives 19
Strength - Orphan Drug Designation - Sodium Thiosulfate 19
Adherex Technologies Inc. - Weaknesses 19
Weakness - History of Operating Losses 19
Weakness - Dependence on Third Parties 20
Adherex Technologies Inc. - Opportunities 20
Opportunity - Collaborations and Licensing Agreements 20
Opportunity - Demographic Trends 20
Opportunity - Growth Potential: Cancer Treatments 20
Adherex Technologies Inc. - Threats 20
Threat - Intense Competition 20
Threat - Industry Consolidation 21
Threat - Uncertain R&D Outcomes 21
Adherex Technologies Inc. - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 23
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 27
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 28
Adherex Technologies Inc., Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Adherex Technologies Inc., Recent Developments 30
Mar 31, 2014: Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2013 Financial Results 30
Nov 22, 2013: Adherex announces closing of private placement 31
Nov 15, 2013: Adherex announces private placement of units 31
Nov 15, 2013: Adherex reports recent developments and third quarter September 30, 2013 financial results 33
Aug 15, 2013: Adherex Announces Corporate Update 34
Aug 09, 2013: Adherex Reports Recent Developments and Second Quarter June 30, 2013 Financial Results 34
May 13, 2013: Adherex Technologies Reports Q1 2013 Results 36
Apr 01, 2013: Adherex Technologies Reports 2012 Results 36
Section 6 – Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42
List Of Tables
List of Tables
Adherex Technologies Inc., Key Facts 5
Adherex Technologies Inc., Key Employees 6
Adherex Technologies Inc., Key Employee Biographies 7
Adherex Technologies Inc., Major Products and Services 8
Adherex Technologies Inc., Number of Pipeline Products by Therapy Area 9
Adherex Technologies Inc., Number of Pipeline Products by Development Stage 10
Adherex Technologies Inc., Pipeline Products By Therapy Area and Development Phase 11
Adherex Technologies Inc., History 12
Adherex Technologies Inc., Subsidiaries 16
Adherex Technologies Inc., Key Competitors 22
Adherex Technologies Inc., Ratios based on current share price 23
Adherex Technologies Inc., Annual Ratios 23
Adherex Technologies Inc., Interim Ratios 25
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 27
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 28
Adherex Technologies Inc., Recent Deals Summary 29
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41
List Of Figures
List of Figures
Adherex Technologies Inc., Pipeline Products by Therapy Area 9
Adherex Technologies Inc., Pipeline Products by Development Phase 10
Adherex Technologies Inc., Performance Chart (2009 - 2013) 24
Adherex Technologies Inc., Ratio Charts 26
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 27
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 28
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter